Clinical Evaluation of a New Automated Bridge Assay for the Detection of Thyroid-Stimulating Hormone Receptor Autoantibodies
Hormone and Metabolic Research · 01.02.2026 · 58 (02) · 56-52
DOI: 10.1055/a-2797-6441 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.02.2026. Verfasst von Patricia Schott-Ohly und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division for Specific Endocrinology, University Hospital Duesseldorf Centre for Health and Society, Duesseldorf, Germany. Hauptthemen laut MEDLINE: Receptors, Thyrotropin, Autoantibodies, Graves Disease, Luminescent Measurements. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: This study has been supported by the Diasorin Italia S.p.A..
Abstract (Originalsprache)
Graves’ disease is an autoimmune disease caused by autoantibodies to the thyroid-stimulating hormone receptor, which usually leads to hyperthyroidism in these patients. The aim of the present study was to evaluate a new automated bridge chemiluminescence thyroid-stimulating hormone receptor autoantibody assay for the diagnosis and in the follow-up of Graves’ disease patients and to compare this assay with another established competition assay. Altogether, 132 Graves’ disease, 39 autoimmune thyroiditis, 28 non-autoimmune nodular goiter and 27 thyroid cancer patients were included in this study. Receiver-operating characteristic plot analysis based on above mentioned samples revealed an area under the curve of 0.9994 (95% confidence interval: 0.9980–1.001), indicating high sensitivity and specificity of the assay. The optimal sensitivity (99.22%; 95% confidence interval: 95.7–99.8%) and specificity (98.98%; 95% confidence interval: 94.4%–99.8%) were seen at a cut-off level of 0.550 IU/L. The corresponding positive predictive value was 99.22%, whereas the negative predictive value was estimated to be 98.98%. A detailed comparison of the two assay systems used revealed a slightly different thyroid-stimulating hormone receptor autoantibody distribution with the new bridge assay detecting more thyroid-stimulating hormone receptor autoantibody-positive follow-up patients with active Graves’ disease compared with the competition assay. The measurement of thyroid-stimulating hormone receptor autoantibodies revealed a steady decline over the time of follow-up. In summary, our results demonstrate that the new automated bridge assay for detecting thyroid-stimulating hormone receptor autoantibodies has high sensitivity and specificity for diagnosing Graves’ disease and to discriminate from other thyroid diseases, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division for Specific Endocrinology, University Hospital Duesseldorf Centre for Health and Society, Duesseldorf, Germany.
- Division for Specific Endocrinology, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.
- Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Duesseldorf Centre for Health and Society, Duesseldorf, Germany.
- Institute for Virology, University Hospital Duesseldorf Centre for Health and Society, Duesseldorf, Germany.
- Institute of Medical Microbiology and Hospital Hygiene, University Hospital Duesseldorf Centre for Health and Society, Duesseldorf, Germany.
- Clinic for Nuclear Medicine, University Hospital Duesseldorf, Duesseldorf, Germany.
Förderung
- This study has been supported by the Diasorin Italia S.p.A.
Zitieren
APA
Schott-Ohly, P., Albeiruty, S., Muchalla, M., Doetter, U., Hommen, J., Eberwein, T., Vogkou, C., Hermsen, D., Timm, J., MacKenzie, C., Giesel, F., & Schott, M. (2026). Clinical Evaluation of a New Automated Bridge Assay for the Detection of Thyroid-Stimulating Hormone Receptor Autoantibodies. Hormone and Metabolic Research, 58(02), 56-52. https://doi.org/10.1055/a-2797-6441
Vancouver
Schott-Ohly P, Albeiruty S, Muchalla M, Doetter U, Hommen J, Eberwein T, et al. Clinical Evaluation of a New Automated Bridge Assay for the Detection of Thyroid-Stimulating Hormone Receptor Autoantibodies. Hormone and Metabolic Research. 2026;58(02):56-52. doi:10.1055/a-2797-6441
BibTeX
@article{SchottOhly2026,
author = {Schott-Ohly, Patricia and Albeiruty, Samer and Muchalla, Mareike and Doetter, Ursula and Hommen, Jann and Eberwein, Tanja and Vogkou, Christiana and Hermsen, Derik and Timm, Joerg and MacKenzie, Colin and Giesel, Frederik and Schott, Matthias},
title = {Clinical Evaluation of a New Automated Bridge Assay for the Detection of Thyroid-Stimulating Hormone Receptor Autoantibodies},
journal = {Hormone and Metabolic Research},
year = {2026},
volume = {58},
number = {02},
pages = {56--52},
doi = {10.1055/a-2797-6441}
}
EUVIMED